Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAY.1.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XAY.1.1.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
BA.2.25.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.2.25.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.2.25.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.25.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.2.25.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.25.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.2.25.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.25.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XADORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XADORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XADORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XADORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XADSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XADNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XADNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XADORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
XABORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XABORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XABORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XABORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XABSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XABNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XABNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XABORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
CH.1.1.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
CH.1.1.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
CH.1.1.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
CH.1.1.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
CH.1.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
CH.1.1.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CH.1.1.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
FT.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
FT.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
FT.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FT.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
FT.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
FT.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
FT.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FT.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XALORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XALORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XALORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XALORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XALSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XALNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XALNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XALORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used